Report Overview:
Venous foot pumps are specialized medical devices designed to enhance blood circulation in lower extremities by mimicking natural leg muscle movements. These noninvasive devices apply rhythmic pressure to the plantar venous plexus, effectively preventing venous stasis and reducing thrombosis risk. They are particularly beneficial for post-surgical patients and those with chronic venous insufficiency or limited mobility.
The market growth is primarily driven by increasing venous disease prevalence, with over 40% of adults in developed nations affected by chronic venous disorders. However, adoption rates vary significantly by region due to cost sensitivity and competition from alternative therapies like compression stockings. North America currently dominates the market with over 30% revenue share, while desktop-type pumps account for more than 99% of total unit sales, reflecting strong hospital demand for stationary models.
Market Value:
Global venous foot pump market size was valued at USD 212 million in 2023. The market is projected to grow from USD 225 million in 2024 to USD 304 million by 2030, exhibiting a CAGR of 5.4% during the forecast period.
By Applications:
Hospitals and Clinics
Rehabilitation Centers
Home Care
By Types:
Desktop
Vertical
Key players include:
• Cardinal Health (U.S.)
• ArjoHuntleigh (Sweden)
• Zimmer Biomet (U.S.)
• DJO (Enovis) (U.S.)
• Breg (U.S.)
• Devon Medical Products (U.S.)
• Mego Afek (Israel)
• Bio Compression Systems (U.S.)
